Evidence map›Paper›PMID 36682217›Full record

ArticleJournal of geriatric oncology2023

The role of self-perceived age in older adults considering adjuvant chemotherapy.

Sule Yilmaz, Fatoumata Koita, Jason Zittel, Megan Wells, Supriya Mohile, Marsha Wittink, J MacLaren Kelly, Mina Sedrak, Lauren DeCaporale-Ryan, Grace DiGiovanni and 1 more

Abstract read
In one paragraph

Article in Journal of geriatric oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sule YilmazUniversity of Rochester, Rochester, NY, United States of America. Electronic address: sule_yilmaz@urmc.rochester.edu.
Fatoumata KoitaState University of New York at Albany, Albany, NY, United States of America.
Jason ZittelUniversity of Rochester, Rochester, NY, United States of America.
Megan WellsUniversity of Rochester, Rochester, NY, United States of America.
Supriya MohileUniversity of Rochester, Rochester, NY, United States of America.
Marsha WittinkUniversity of Rochester, Rochester, NY, United States of America.
J MacLaren KellyUniversity of Rochester, Rochester, NY, United States of America.
Mina SedrakCity of Hope, Duarte, CA, United States of America.
Lauren DeCaporale-RyanUniversity of Rochester, Rochester, NY, United States of America.
Grace DiGiovanniUniversity of Rochester, Rochester, NY, United States of America.
Allison MagnusonUniversity of Rochester, Rochester, NY, United States of America.

Funding

URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN · 2014 to 2026
$67.7M
Oncology Research Career Development ProgramK12CA001727 · NCI · CITY OF HOPE NATIONAL MEDICAL CENTER · PI MORTIMER, JOANNE E. · 1992 to 2024
$14.6M
Geriatric Oncology Research Infrastructure to Improve Clinical CareR33AG059206 · NIA · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI WILLIAM DALE, Heidi Diana Klepin · 2020 to 2026
$5.1M
Clinical and Translational Cancer Control Research Training ProgramT32CA102618 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, Gary R Morrow · 2019 to 2026
$2.7M
A Patient-Oriented Research Program in Geriatric OncologyK24AG056589 · NIA · UNIVERSITY OF ROCHESTER · PI Supriya G. Mohile · 2018 to 2026
$1.5M
Mitigating Cancer-Related Cognitive Dysfunction in Older Adults with Breast CancerK76AG064394 · NIA · UNIVERSITY OF ROCHESTER · PI MAGNUSON, ALLISON MARIAN · 2019 to 2023
$1.3M
NCI NIH HHS K12 CA001727NCI NIH HHS T32 CA102618NCI NIH HHS UG1 CA189961NIA NIH HHS K24 AG056589NIA NIH HHS K76 AG064394NIA NIH HHS R33 AG059206
6 · The paper itself

Abstract

introductionAging-related concerns can increase the risk of treatment toxicities among older adults considering adjuvant chemotherapy. We previously demonstrated that older adults with cancer who reported feeling older than their chronological age (i.e., self-perceived age) were more likely to have aging-related concerns identified during a geriatric assessment. We explored how decisions about adjuvant chemotherapy vary with or are related to older adults' self-perceived age. MATERIALS AND

methodsWe conducted a secondary analysis of a multi-phased feasibility pilot using semi-structured interviews that were conducted to explore the patient decision-making process for adjuvant chemotherapy. Interviews incorporated questions about chronological and perceived age as factors for decision-making. Patient eligibility for the study included (1) age ≥ 70 years and older, (2) a diagnosis of breast, colon, or lung cancer and considering adjuvant chemotherapy, and (3) able to read size 18 font in English. Interview data were analyzed using constant comparative method.

resultsTwenty-one patients were enrolled. The mean chronological age was 78 years (range 71-91). The average perceived age of patients was 57 years (range 21-80). Eleven patients chose to receive treatment while ten patients did not. Aging-related themes illustrated that self-perceived age plays an important role when patients make decisions about adjuvant chemotherapy. More specifically, patients who reported their self-perceived age as younger than their chronological age also reported better perceived health status and chose to receive adjuvant chemotherapy. DISCUSSION: Patients' experiences of aging and self-perceived age may have different implications for decision-making.

Indexed as

Breast NeoplasmsLung NeoplasmsAgedAged, 80 and overAge FactorsAgingChemotherapy, AdjuvantFemaleHealth StatusHumansAdjuvant chemotherapyDecision-making processGeriatric assessmentOlder adultsSelf-perceived age

Identifiers

PMID36682217
PMCPMC9974899

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.